Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Total 13F shares
-
48,795,904
-
Share change
-
+2,449,613
-
Total reported value
-
$265,941,291
-
Put/Call ratio
-
88%
-
Price per share
-
$5.45
-
Number of holders
-
96
-
Value change
-
-$13,062,768
-
Number of buys
-
56
-
Number of sells
-
41
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q3 2019
As of 30 Sep 2019,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,795,904 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, STATE STREET CORP, BlackRock Inc., Avoro Capital Advisors LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, DIMENSIONAL FUND ADVISORS LP, and Ghost Tree Capital, LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.